Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115702) titled 'Analysis of Efficacy and Risk Factors for Primary Prevention of Neutropenia in Cancer Patients Under Standardized Nutritional Intervention' on Dec. 30, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Anqing First People's Hospital
Condition:
Neutropenia in tumor patients
Intervention:
experimental group:The efficacy and risk control of primary prevention of neutropenia or FN caused by anti-tumor therapy in solid tumors with Mecapegfilgrastim Injection
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-05-01
Target Sample Size: experimental group:50;...